Atlas FDA

Exogen

FDA premarket approval P900009/S048 · decided 2022-01-07

Approval details

PMA number
P900009
Supplement
S048
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Exogen
Generic name
Stimulator, bone growth, non-invasive
Applicant
Bioventus, LLC
Date received
2021-12-03
Decision date
2022-01-07
Days to decision
35 days
Decision code
OK30
Product code
LOF
Advisory committee
Orthopedic
Expedited review
No
Location
Durham, NC
Statement
Use an additional supplier for the plastic housing components of the Main Operating Unit of the EXOGEN® Ultrasound Bone Healing System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
StimTrial Neuromodulation System (K243782)Bioventus, LLC2025-07-16
TalisMann Neuromodulation System (K243678)Bioventus, LLC2025-07-03
Allograft Delivery Device (OFAC-C) (K233368)Bioventus, LLC2024-06-25
SIGNAFUSE Bioactive Strip (SBS); SIGNAFUSE Putty (K233490)Bioventus, LLC2023-12-05
MCS Bone Graft (K162860)Bioventus, LLC2017-02-13